MedPath

LUNAN BETTER PHARMACEUTICAL CO., LTD.

LUNAN BETTER PHARMACEUTICAL CO., LTD. logo
🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

3 Phases

Phase 2:1
Phase 3:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (33.3%)
Phase 2
1 (33.3%)
Phase 3
1 (33.3%)

Pharmacokinetics and Bioequivalence Study of Budesonide Inhalation Aerosol in Humans

Not Applicable
Completed
Conditions
Bioequivalence Study in Healthy Subjects
Interventions
Drug: Budiair® 200ug/puff inhalation aerosol
Drug: budesonide 200ug/puff inhalation aerosol
First Posted Date
2025-04-11
Last Posted Date
2025-04-11
Lead Sponsor
Lunan Better Pharmaceutical Co., LTD.
Target Recruit Count
32
Registration Number
NCT06924190
Locations
🇨🇳

Wuxi People's Hospital, Wuxi, Jiangsu, China

🇨🇳

Lunan Better Pharmaceutical Co., Ltd., Linyi, Shandong, China

Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease

Phase 3
Recruiting
Conditions
Dry Eye Disease (DED)
Interventions
Drug: Drug placebo
First Posted Date
2025-03-17
Last Posted Date
2025-03-17
Lead Sponsor
Lunan Better Pharmaceutical Co., LTD.
Target Recruit Count
820
Registration Number
NCT06879782
Locations
🇨🇳

Beijing Tongren Hospital, Capital Medical University, Peking, Beijing, China

Efficacy and Safety of Isosorbide Oral Solution in Patients With Meniere's Disease

Phase 2
Not yet recruiting
Conditions
Meniere´s Disease
Interventions
Drug: Isosorbide oral solution
Drug: Placebo
First Posted Date
2025-01-09
Last Posted Date
2025-01-09
Lead Sponsor
Lunan Better Pharmaceutical Co., LTD.
Target Recruit Count
234
Registration Number
NCT06765993

News

No news found
© Copyright 2025. All Rights Reserved by MedPath